Secondary B Cell Receptor Diversification Is Necessary for T Cell Mediated Neuro-Inflammation during Experimental Autoimmune Encephalomyelitis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Galicia, Georgina ^a   Boulianne, Bryant ^a   Pikor, Natalia ^a   Martin, Alberto ^a   Gommerman, Jennifer L ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATION INDUCED CYTIDINE DEAMINASE; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 17; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY; PROTEIN ANTIBODY; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AICDA (ACTIVATION-INDUCED CYTIDINE DEAMINASE); CELL SURFACE RECEPTOR; CYTIDINE DEAMINASE; CYTOKINE; IMMUNOGLOBULIN M;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; BIOACCUMULATION; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; LYMPHATIC DRAINAGE; LYMPHOCYTE MIGRATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PROTEIN DOMAIN; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE PRIMING; ANIMAL; B LYMPHOCYTE; BRAIN; DEFICIENCY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNIZATION; IMMUNOLOGY; LYMPH NODE; METABOLISM; T LYMPHOCYTE;

ANIMALIA; MUS;

ANIMALS; B-LYMPHOCYTES; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CYTIDINE DEAMINASE; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN M; LYMPH NODES; MICE; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; RECEPTORS, CELL SURFACE; T-LYMPHOCYTES;

EID: 84876435854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061478     Document Type: Article

References (46)

1. Kabat EA, Glusman M, Knaub V, (1948) Quantitative estimation of the albumin and gamma globulin in normal and pathologic cerebrospinal fluid by immunochemical methods. Am J Med 4: 653-662.
2. Prineas JW, Wright RG, (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest 38: 409-421.
3. Henderson AP, Barnett MH, Parratt JD, Prineas JW, (2009) Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Ann Neurol 66: 739-753.
4. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, et al. (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47: 707-717.
5. Lovato L, Willis SN, Rodig SJ, Caron T, Almendinger SE, et al. (2011) Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 134: 534-541.
6. Di Pauli F, Gredler V, Kuenz B, Lutterotti A, Ehling R, et al. (2010) Features of intrathecal immunoglobulins in patients with multiple sclerosis. J Neurol Sci 288: 147-150.
7. Kuenz B, Lutterotti A, Ehling R, Gneiss C, Haemmerle M, et al. (2008) Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 3: e2559.
8. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F, (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14: 164-174.
9. Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, et al. (2008) B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N Engl J Med 358: 676-688.
10. Kappos L, Li D, Calabresi PA, O'Connor P, Bar-Or A, et al. (2011) Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet 378: 1779-1787.
11. Hjelmstrom P, Juedes AE, Fjell J, Ruddle NH, (1998) B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization. J Immunol 161: 4480-4483.
12. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM, (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950.
13. Matsushita T, Yanaba K, Bouaziz JD, Fujimoto M, Tedder TF, (2008) Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 118: 3420-3430.
14. von Budingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, et al. (2002) Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc Natl Acad Sci U S A 99: 8207-8212.
15. Lyons JA, San M, Happ MP, Cross AH, (1999) B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur J Immunol 29: 3432-3439.
16. Monson NL, Cravens P, Hussain R, Harp CT, Cummings M, et al. (2011) Rituximab therapy reduces organ-specific T cell responses and ameliorates experimental autoimmune encephalomyelitis. PLoS One 6: e17103.
17. Kuerten S, Javeri S, Tary-Lehmann M, Lehmann PV, Angelov DN, (2008) Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. Clin Immunol 129: 256-267.
18. Baranzini SE, Jeong MC, Butunoi C, Murray RS, Bernard CC, et al. (1999) B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions. J Immunol 163: 5133-5144.
19. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, et al. (2000) Accumulation of clonally related B lymphocytes in the cerebrospinal fluid of multiple sclerosis patients. J Immunol 164: 2782-2789.
20. Obermeier B, Mentele R, Malotka J, Kellermann J, Kumpfel T, et al. (2008) Matching of oligoclonal immunoglobulin transcriptomes and proteomes of cerebrospinal fluid in multiple sclerosis. Nat Med 14: 688-693.
21. Owens GP, Kraus H, Burgoon MP, Smith-Jensen T, Devlin ME, et al. (1998) Restricted use of VH4 germline segments in an acute multiple sclerosis brain. Ann Neurol 43: 236-243.
22. Qin Y, Duquette P, Zhang Y, Talbot P, Poole R, et al. (1998) Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. J Clin Invest 102: 1045-1050.
23. Harp C, Lee J, Lambracht-Washington D, Cameron E, Olsen G, et al. (2007) Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection. J Neuroimmunol 183: 189-199.
24. Qin Y, Duquette P, Zhang Y, Olek M, Da RR, et al. (2003) Intrathecal B-cell clonal expansion, an early sign of humoral immunity, in the cerebrospinal fluid of patients with clinically isolated syndrome suggestive of multiple sclerosis. Lab Invest 83: 1081-1088.
25. Ritchie AM, Gilden DH, Williamson RA, Burgoon MP, Yu X, et al. (2004) Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis. J Immunol 173: 649-656.
26. Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, et al. (2000) Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102: 553-563.
27. Revy P, Muto T, Levy Y, Geissmann F, Plebani A, et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102: 565-575.
28. Petersen-Mahrt SK, Harris RS, Neuberger MS, (2002) AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 418: 99-104.
29. Di Noia J, Neuberger MS, (2002) Altering the pathway of immunoglobulin hypermutation by inhibiting uracil-DNA glycosylase. Nature 419: 43-48.
30. Martin A, Bardwell PD, Woo CJ, Fan M, Shulman MJ, et al. (2002) Activation-induced cytidine deaminase turns on somatic hypermutation in hybridomas. Nature 415: 802-806.
31. Bransteitter R, Pham P, Scharff MD, Goodman MF, (2003) Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proc Natl Acad Sci U S A 100: 4102-4107.
32. Sekiguchi Y, Ichikawa M, Takamoto M, Ota H, Koh CS, et al. (2009) Antibodies to myelin oligodendrocyte glycoprotein are not involved in the severity of chronic non-remitting experimental autoimmune encephalomyelitis. Immunol Lett 122: 145-149.
33. Muramatsu M, Sankaranand VS, Anant S, Sugai M, Kinoshita K, et al. (1999) Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J Biol Chem 274: 18470-18476.
34. deLuca LE, Pikor NB, O'Leary J, Galicia-Rosas G, Ward LA, et al. (2010) Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis. J Immunol 184: 3174-3185.
35. Lyons JA, Ramsbottom MJ, Cross AH, (2002) Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein. Eur J Immunol 32: 1905-1913.
36. Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH, (2005) Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A 102: 13992-13997.
37. Sun Y, Peng I, Senger K, Hamidzadeh K, Reichelt M, et al. (2013) Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis. Autoimmunity.
38. Walsh MJ, Tourtellotte WW, Roman J, Dreyer W, (1985) Immunoglobulin G, A, and M-clonal restriction in multiple sclerosis cerebrospinal fluid and serum-analysis by two-dimensional electrophoresis. Clin Immunol Immunopathol 35: 313-327.
39. Burgoon MP, Keays KM, Owens GP, Ritchie AM, Rai PR, et al. (2005) Laser-capture microdissection of plasma cells from subacute sclerosing panencephalitis brain reveals intrathecal disease-relevant antibodies. Proc Natl Acad Sci U S A 102: 7245-7250.
40. Gilden DH, (2005) Infectious causes of multiple sclerosis. Lancet Neurol 4: 195-202.
41. Sindic CJ, Monteyne P, Laterre EC, (1994) The intrathecal synthesis of virus-specific oligoclonal IgG in multiple sclerosis. J Neuroimmunol 54: 75-80.
42. Jiang C, Zhao ML, Waters KM, Diaz M, (2012) Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity. Autoimmunity 45: 440-448.
43. Yoshizaki A, Miyagaki T, Dilillo DJ, Matsushita T, Horikawa M, et al. (2012) Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature.
44. Zaheen A, Boulianne B, Parsa JY, Ramachandran S, Gommerman JL, et al. (2009) AID constrains germinal center size by rendering B cells susceptible to apoptosis. Blood 114: 547-554.
45. Wu GF, Shindler KS, Allenspach EJ, Stephen TL, Thomas HL, et al. (2011) Limited sufficiency of antigen presentation by dendritic cells in models of central nervous system autoimmunity. J Autoimmun 36: 56-64.
46. Giuliani F, Metz LM, Wilson T, Fan Y, Bar-Or A, et al. (2005) Additive effect of the combination of glatiramer acetate and minocycline in a model of MS. J Neuroimmunol 158: 213-221.